REMS
An FDA risk-management program some drugs require. GLP-1s do not have one.
A Risk Evaluation and Mitigation Strategy is an FDA-required safety program for certain high-risk drugs (e.g. isotretinoin's iPLEDGE). GLP-1s do not carry a REMS, though they do carry a boxed warning.